Evidence map›Paper›PMID 23333851›Full record

ArticleInternational journal of surgery case reports2013

Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review.

Benedetto Ielpo, Riccardo Caruso, Valentina Ferri, Yolanda Quijano, Hipolito Duran, Eduardo Diaz, Isabel Fabra, Ramon Puga, Catalina Oliva, Sergio Olivares and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of surgery case reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Giant Malignant Insulinoma.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2016
    Article
  7. Giant insulinoma in a 15-year-old man: A case report.International journal of surgery case reports · 2016
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Benedetto IelpoMadrid Sanchinarro University Hospital, General Surgery Department, San Pablo University, CEU, Madrid, Spain. Electronic address: ielpo.b@gmail.com.
Riccardo Caruso
Valentina Ferri
Yolanda Quijano
Hipolito Duran
Eduardo Diaz
Isabel Fabra
Ramon Puga
Catalina Oliva
Sergio Olivares
Emilio Vicente
Universidad San Pablo CEU · ESHospital Universitario HM Sanchinarro · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGiant pancreatic insulinomas are rare endocrine tumors. We describe 2 cases reviewing the current literature. PRESENTATION OF CASE: We report herein 2 female patients affected by giant insulinomas of 14cm and 6cm, respectively. Symptomatic hypoglycemia episodes occurred during 4 months in first case and 3 years in the second one until diagnosis. Both patients were successfully treated performing a distal pancreatectomy with splenic preservation in the first case and a Whipple's procedure in the second one. DISCUSSION: Up to now only 7 cases have been reported previously. Insulinomas larger than 3cm accounts for less than 5% of all. This literature review shows that despite the size hypoglycemic symptoms varies from 1 day to 3 years and only 1 out of 9 cases reported presented lymph nodes metastases. No recurrences have been described.

conclusionOne of the cases here described (14cm) is the largest presented in the literature. Despite the size, giant insulinoma is related apparently neither to metastases nor to the recurrences.

Identifiers

PMID23333851
PMCPMC3604667
OpenAlexW1978553897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.